Depression, whether it's diagnosed or not, can have several negative effects on the health of cardiovascular disease (CVD) patients, according to new research presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

ZIP codes may be related to the prevalence of obesity, according to new research from the University of Arkansas, published April 4 in Obesity Research & Clinical Practice.

Out-of-pocket expenses for the treatment of chronic heart disease lead to significant financial burdens for low-income families, even for those with health insurance, according to preliminary research presented April 6 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

Amid ongoing controversies involving misuse of information about its users, Facebook has shelved plans to share user data with several major U.S. hospitals. CNBC reported the social media giant had scientists approach organizations, including the American College of Cardiology, about the project.

According to a new study in JAMA, people who lost at least 75 percent of their net worth in a two-year period showed a 50 percent increased risk of dying over two decades compared to those who maintained positive wealth.

Outcomes-based pricing agreements would do little to help the poor cost-effectiveness of PCSK9 inhibitors. The event rates in preventive medicine are simply too low and medication costs too high for such a compromise to make a difference, a group from University of California, San Francisco reported in the Annals of Internal Medicine.

GE Healthcare has announced it will sell its revenue cycle, ambulatory care and workforce management software units to private equity firm Veritas Capital for $1.05 billion, following earlier plans for General Electric to sell assets and rumors the entire company could be broken up.

The number of patients admitted to U.S. hospitals for infective endocarditis (IE) related to IV drug use has more than doubled over the last several years, racking up an average of $72,000 in expenses each time.